Skip to content
akaturk Academic measurement
Sign in Sign up

OpenAlex topic

Myasthenia Gravis and Thymoma

This page lists works and academicians tagged with an OpenAlex topic. It is not a YÖKSİS primary or secondary field.

OpenAlex 1,826 works 36 author topics

Works

1,826 works

  1. Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study 2017
    YÖKSİS SJR Q1 JCR Q1 OpenAlex top 1% OpenAlex 99.9%

    No abstract yet.

  2. Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study 2017
    YÖKSİS SJR Q1 JCR Q1 OpenAlex top 1% OpenAlex 99.9%

    No abstract yet.

  3. Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study 2017
    YÖKSİS SJR Q1 JCR Q1 OpenAlex top 1% OpenAlex 99.9%

    No abstract yet.

  4. The IASLC/ITMIG Thymic Epithelial Tumors Staging Project: Proposal for an Evidence-Based Stage Classification System for the Forthcoming (8th) Edition of the TNM Classification of Malignant Tumors 2014
    YÖKSİS SJR Q1 JCR Q1 OpenAlex top 1% OpenAlex 99.7%

    No abstract yet.

  5. Initial Analysis of the International Association For the Study of Lung Cancer Mesothelioma Database 2012
    OpenAlex top 1% OpenAlex 99.6%

    No abstract yet.

  6. Histopathological grading of pediatric ependymoma: reproducibility and clinical relevance in European trial cohorts 2011
    YÖKSİS SJR Q2 OpenAlex top 10% OpenAlex 93.9%

    BACKGROUND: Histopathological grading of ependymoma has been controversial with respect to its reproducibility and clinical significance. In a 3-phase study, we reviewed the pathology of 229 intracranial ependymomas from European trial cohorts of infants (2 trials - SFOP/CNS9204) and older children (2 trials - AIEOP/C…

  7. Long‐term safety and efficacy of eculizumab in generalized myasthenia gravis 2019
    YÖKSİS SJR Q2 JCR Q3 OpenAlex top 1% OpenAlex 99.6%

    INTRODUCTION: Eculizumab is effective and well tolerated in patients with antiacetylcholine receptor antibody-positive refractory generalized myasthenia gravis (gMG; REGAIN; NCT01997229). We report an interim analysis of an open-label extension of REGAIN, evaluating eculizumab's long-term safety and efficacy. METHODS:…

  8. Long‐term safety and efficacy of eculizumab in generalized myasthenia gravis 2019
    YÖKSİS SJR Q2 JCR Q3 OpenAlex top 1% OpenAlex 99.6%

    INTRODUCTION: Eculizumab is effective and well tolerated in patients with antiacetylcholine receptor antibody-positive refractory generalized myasthenia gravis (gMG; REGAIN; NCT01997229). We report an interim analysis of an open-label extension of REGAIN, evaluating eculizumab's long-term safety and efficacy. METHODS:…

  9. The IASLC/ITMIG Thymic Epithelial Tumors Staging Project: Proposals for the T component for the Forthcoming (8th) Edition of the TNM Classification of Malignant Tumors 2014
    YÖKSİS SJR Q1 JCR Q1 OpenAlex top 10% OpenAlex 98.8%

    No abstract yet.

  10. The IASLC Mesothelioma Staging Project: Proposals for Revisions of the N Descriptors in the Forthcoming Eighth Edition of the TNM Classification for Pleural Mesothelioma 2016
    YÖKSİS SJR Q1 JCR Q1 OpenAlex top 1% OpenAlex 99.4%

    No abstract yet.

  11. The IASLC Mesothelioma Staging Project: Proposals for Revisions of the T Descriptors in the Forthcoming Eighth Edition of the TNM Classification for Pleural Mesothelioma 2016
    OpenAlex top 1% OpenAlex 99.3%

    No abstract yet.

  12. Long term outcome of patients with spinal myxopapillary ependymoma treatment results from the MD Anderson Cancer Center and institutions from the Rare Cancer Network 2015
    YÖKSİS SJR Q1 JCR Q1 OpenAlex 89.3%

    BACKGROUND: Spinal myxopapillary ependymomas (MPEs) are slowly growing ependymal gliomas with preferential manifestation in young adults. The aim of this study was to assess the outcome of patients with MPE treated with surgery, radiotherapy (RT), and/or chemotherapy. METHODS: The medical records of 183 MPE patients (…

Academicians

36 academicians